Llwytho...
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...
Wedi'i Gadw mewn:
Prif Awduron: | , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
MDPI AG
2020-10-01
|
Cyfres: | Cancers |
Pynciau: | |
Mynediad Ar-lein: | https://www.mdpi.com/2072-6694/12/10/2993 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|